ReP USP - Resultado da busca

Artigo de periodico
Return to work after breast cancer diagnosis: an observational prospective study in Brazil (2018)
Landeiro, Luciana C. G.; Gagliato, Debora M.; Fede, Angelo B.; Fraile, Natalia M.; Lopez, Rossana M.; Fonseca, Leonardo G. da; Petry, Vanessa; Testa, Laura; Hoff, Paulo Marcelo Gehm; Mano, Max Senna
Source: Cancer. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, QUALIDADE DE VIDA NO TRABALHO, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LANDEIRO, Luciana C. G. et al. Return to work after breast cancer diagnosis: an observational prospective study in Brazil. Cancer, v. 124, n. 24, p. 4700-4710, 2018Tradução . . Disponível em: https://doi.org/10.1002/cncr.31735. Acesso em: 14 nov. 2024.
APA
Landeiro, L. C. G., Gagliato, D. M., Fede, A. B., Fraile, N. M., Lopez, R. M., Fonseca, L. G. da, et al. (2018). Return to work after breast cancer diagnosis: an observational prospective study in Brazil. Cancer, 124( 24), 4700-4710. doi:10.1002/cncr.31735
NLM
Landeiro LCG, Gagliato DM, Fede AB, Fraile NM, Lopez RM, Fonseca LG da, Petry V, Testa L, Hoff PMG, Mano MS. Return to work after breast cancer diagnosis: an observational prospective study in Brazil [Internet]. Cancer. 2018 ; 124( 24): 4700-4710.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.31735
Vancouver
Landeiro LCG, Gagliato DM, Fede AB, Fraile NM, Lopez RM, Fonseca LG da, Petry V, Testa L, Hoff PMG, Mano MS. Return to work after breast cancer diagnosis: an observational prospective study in Brazil [Internet]. Cancer. 2018 ; 124( 24): 4700-4710.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.31735
Artigo de periodico
Targeting the interleukin-11 receptor a in metastatic prostate cancer: a first-in-man study (2015)
Pasqualini, Renata; Millikan, Randall E; Christianson, Dawn R; Cardó-Vila, Marina; Driessen, Wouter H. P; Giordano, Ricardo José ; Hajitou, Amin; Hoang, Anh G; Wen, Sijin; Barnhart, Kirstin F; Baze, Wallace B; Marcott, Valerie D; Hawke, David H; Do, Kim-Anh; Navone, Nora M; Efstathiou, Eleni; Troncoso, Patricia; Lobb, Roy R; Logothetis, Christopher J; Arap, Wadih
Source: Cancer. Unidade: IQ
Subjects: INTERLEUCINAS, NEOPLASIAS DOS GENITAIS MASCULINOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASQUALINI, Renata et al. Targeting the interleukin-11 receptor a in metastatic prostate cancer: a first-in-man study. Cancer, v. 121, n. 14, p. 2411-2421, 2015Tradução . . Disponível em: https://doi.org/10.1002/cncr.29344. Acesso em: 14 nov. 2024.
APA
Pasqualini, R., Millikan, R. E., Christianson, D. R., Cardó-Vila, M., Driessen, W. H. P., Giordano, R. J., et al. (2015). Targeting the interleukin-11 receptor a in metastatic prostate cancer: a first-in-man study. Cancer, 121( 14), 2411-2421. doi:10.1002/cncr.29344
NLM
Pasqualini R, Millikan RE, Christianson DR, Cardó-Vila M, Driessen WHP, Giordano RJ, Hajitou A, Hoang AG, Wen S, Barnhart KF, Baze WB, Marcott VD, Hawke DH, Do K-A, Navone NM, Efstathiou E, Troncoso P, Lobb RR, Logothetis CJ, Arap W. Targeting the interleukin-11 receptor a in metastatic prostate cancer: a first-in-man study [Internet]. Cancer. 2015 ; 121( 14): 2411-2421.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.29344
Vancouver
Pasqualini R, Millikan RE, Christianson DR, Cardó-Vila M, Driessen WHP, Giordano RJ, Hajitou A, Hoang AG, Wen S, Barnhart KF, Baze WB, Marcott VD, Hawke DH, Do K-A, Navone NM, Efstathiou E, Troncoso P, Lobb RR, Logothetis CJ, Arap W. Targeting the interleukin-11 receptor a in metastatic prostate cancer: a first-in-man study [Internet]. Cancer. 2015 ; 121( 14): 2411-2421.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.29344
Artigo de periodico
TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target (2014)
Silva, Sabrina Daniela da; Alaoui-Jamali , Moulay A.; Soares, Fernando Augusto; Carraro, Dirce Maria; Brentani, Helena Paula; Hier, Michael; Rogatto, Silvia Regina; Kowalski, Luiz Paulo
Source: Cancer. Unidade: FO
Subjects: METÁSTASE NEOPLÁSICA, CARCINOMA DE CÉLULAS ESCAMOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Sabrina Daniela da et al. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer, v. 120, n. 3, p. 352-362, 2014Tradução . . Disponível em: https://doi.org/10.1002/cncr.28404. Acesso em: 14 nov. 2024.
APA
Silva, S. D. da, Alaoui-Jamali , M. A., Soares, F. A., Carraro, D. M., Brentani, H. P., Hier, M., et al. (2014). TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer, 120( 3), 352-362. doi:10.1002/cncr.28404
NLM
Silva SD da, Alaoui-Jamali MA, Soares FA, Carraro DM, Brentani HP, Hier M, Rogatto SR, Kowalski LP. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target [Internet]. Cancer. 2014 ; 120( 3): 352-362.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.28404
Vancouver
Silva SD da, Alaoui-Jamali MA, Soares FA, Carraro DM, Brentani HP, Hier M, Rogatto SR, Kowalski LP. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target [Internet]. Cancer. 2014 ; 120( 3): 352-362.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.28404
Artigo de periodico
The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality (2014)
Ebrahimi, Ardalan; Gil, Ziv; Amit, Moran; Yen, Tzu-Chen; Liao, Chun-Ta; Chaturvedi, Pankaj; Agarwal, Jai Prakash; Kowalski, Luiz P.; Kohler, Hugo F.; Kreppel, Matthias; Cernea, Claudio R.; Brandao, Jose; Bachar, Gideon; Villaret, Andrea Bolzoni; Fliss, Dan; Fridman, Eran; Robbins, K. Thomas; Shah, Jatin P.; Patel, Snehal G.; Clark, Jonathan R.
Source: Cancer. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, PROGNÓSTICO, ESTADIAMENTO DE NEOPLASIAS, CARCINOMA DE CÉLULAS ESCAMOSAS, LINFONODOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EBRAHIMI, Ardalan et al. The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality. Cancer, v. 120, n. 13, p. 1968-1974, 2014Tradução . . Disponível em: https://doi.org/10.1002/cncr.28686. Acesso em: 14 nov. 2024.
APA
Ebrahimi, A., Gil, Z., Amit, M., Yen, T. -C., Liao, C. -T., Chaturvedi, P., et al. (2014). The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality. Cancer, 120( 13), 1968-1974. doi:10.1002/cncr.28686
NLM
Ebrahimi A, Gil Z, Amit M, Yen T-C, Liao C-T, Chaturvedi P, Agarwal JP, Kowalski LP, Kohler HF, Kreppel M, Cernea CR, Brandao J, Bachar G, Villaret AB, Fliss D, Fridman E, Robbins KT, Shah JP, Patel SG, Clark JR. The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality [Internet]. Cancer. 2014 ; 120( 13): 1968-1974.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.28686
Vancouver
Ebrahimi A, Gil Z, Amit M, Yen T-C, Liao C-T, Chaturvedi P, Agarwal JP, Kowalski LP, Kohler HF, Kreppel M, Cernea CR, Brandao J, Bachar G, Villaret AB, Fliss D, Fridman E, Robbins KT, Shah JP, Patel SG, Clark JR. The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality [Internet]. Cancer. 2014 ; 120( 13): 1968-1974.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.28686
Artigo de periodico
Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial (2013)
Kim, Miranda B.; Chen, Ming-Hui; Castro, Mário de ; Loffredo, Marian; Kantoff, Philip W.; D'Amico, Anthony Victor
Source: Cancer. Unidade: ICMC
Subjects: INFERÊNCIA BAYESIANA, ESTATÍSTICA APLICADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KIM, Miranda B. et al. Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial. Cancer, v. 119, n. 18, p. 3280\20133286, 2013Tradução . . Disponível em: https://doi.org/10.1002/cncr.28202. Acesso em: 14 nov. 2024.
APA
Kim, M. B., Chen, M. -H., Castro, M. de, Loffredo, M., Kantoff, P. W., & D'Amico, A. V. (2013). Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial. Cancer, 119( 18), 3280\20133286. doi:10.1002/cncr.28202
NLM
Kim MB, Chen M-H, Castro M de, Loffredo M, Kantoff PW, D'Amico AV. Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial [Internet]. Cancer. 2013 ; 119( 18): 3280\20133286.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.28202
Vancouver
Kim MB, Chen M-H, Castro M de, Loffredo M, Kantoff PW, D'Amico AV. Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial [Internet]. Cancer. 2013 ; 119( 18): 3280\20133286.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.28202
Artigo de periodico
Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: Long-term results of a prospective trial (National Clinical Trial 00254683) (2012)
Perez, Rodrigo Oliva; Habr-Gama, Angelita; Gama-Rodrigues, Joaquim; Proscurshim, Igor; Sao Juliao, Guilherme Pagin; Lynn, Patricio; Ono, Carla Rachel; Campos, Fabio Guilherme; Sousa, Jr., Afonso Henrique Silva e; Imperiale, Antonio Rocco; Nahas, Sergio Carlos; Buchpiguel, Carlos Alberto
Source: Cancer. Unidade: FM
Subjects: TOMOGRAFIA COMPUTADORIZADA POR EMISSÃO DE PÓSITRON, DIAGNÓSTICO CLÍNICO (AVALIAÇÃO), NEOPLASIAS RETAIS (EFEITOS DE DROGAS;EFEITOS DE RADIAÇÃO), EVOLUÇÃO CLÍNICA, QUIMIOTERAPIA ADJUVANTE, RADIAÇÃO IONIZANTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREZ, Rodrigo Oliva et al. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: Long-term results of a prospective trial (National Clinical Trial 00254683). Cancer, v. 118, n. 14, p. 3501-3511, 2012Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/cncr.26644/pdf. Acesso em: 14 nov. 2024.
APA
Perez, R. O., Habr-Gama, A., Gama-Rodrigues, J., Proscurshim, I., Sao Juliao, G. P., Lynn, P., et al. (2012). Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: Long-term results of a prospective trial (National Clinical Trial 00254683). Cancer, 118( 14), 3501-3511. doi:10.1002/cncr.26644
NLM
Perez RO, Habr-Gama A, Gama-Rodrigues J, Proscurshim I, Sao Juliao GP, Lynn P, Ono CR, Campos FG, Sousa J, Imperiale AR, Nahas SC, Buchpiguel CA. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: Long-term results of a prospective trial (National Clinical Trial 00254683) [Internet]. Cancer. 2012 ; 118( 14): 3501-3511.[citado 2024 nov. 14 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/cncr.26644/pdf
Vancouver
Perez RO, Habr-Gama A, Gama-Rodrigues J, Proscurshim I, Sao Juliao GP, Lynn P, Ono CR, Campos FG, Sousa J, Imperiale AR, Nahas SC, Buchpiguel CA. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: Long-term results of a prospective trial (National Clinical Trial 00254683) [Internet]. Cancer. 2012 ; 118( 14): 3501-3511.[citado 2024 nov. 14 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/cncr.26644/pdf
Artigo de periodico
Chordoma and chodrosarcoma: similar, but quite different, skull base tumors (2007)
Almefty, Kaith; Pravdenkova, Svetlana; Colli, Benedicto Oscar; Al-Mefty, Ossama; Gokden, Murat
Source: Cancer. Unidade: FMRP
Subjects: NEOPLASIAS CRANIANAS, NEOPLASIAS ÓSSEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEFTY, Kaith et al. Chordoma and chodrosarcoma: similar, but quite different, skull base tumors. Cancer, v. 110, n. 11, p. 2457-2467, 2007Tradução . . Disponível em: https://doi.org/10.1002/cncr.23073. Acesso em: 14 nov. 2024.
APA
Almefty, K., Pravdenkova, S., Colli, B. O., Al-Mefty, O., & Gokden, M. (2007). Chordoma and chodrosarcoma: similar, but quite different, skull base tumors. Cancer, 110( 11), 2457-2467. doi:10.1002/cncr.23073
NLM
Almefty K, Pravdenkova S, Colli BO, Al-Mefty O, Gokden M. Chordoma and chodrosarcoma: similar, but quite different, skull base tumors [Internet]. Cancer. 2007 ; 110( 11): 2457-2467.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.23073
Vancouver
Almefty K, Pravdenkova S, Colli BO, Al-Mefty O, Gokden M. Chordoma and chodrosarcoma: similar, but quite different, skull base tumors [Internet]. Cancer. 2007 ; 110( 11): 2457-2467.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.23073
Artigo de periodico
Outcome predictors of 84 patients with hemetologic malignancies and fusarium infection (2003)
Nucci, Márcio; Anaissie, Elias J.; Queiróz-Telles, Flávio; Martins, Carlos A.; Trabasso, Plínio; Solza, Cristiana; Mangini, Cláudia; Simões, Belinda Pinto; Colombo, Arnaldo L.; Vaz, Jorge; Levy, Carlos E.; Costa, Silvia; Moreira, Vaneusa A.; Oliveira, José Salvador; Paraguay, Nestor; Almeida, Gisele Madeira Duboc de; Volterelli, Júlio César; Maiolino, Angelo; Pasquini, Ricardo; Souza, Cármino A.
Source: Cancer. Unidade: FMRP
Subjects: DOENÇAS HEMATOLÓGICAS (PROGNÓSTICO), NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUCCI, Márcio et al. Outcome predictors of 84 patients with hemetologic malignancies and fusarium infection. Cancer, v. 98, n. 2, p. 315-319, 2003Tradução . . Disponível em: https://doi.org/10.1002/cncr.11510. Acesso em: 14 nov. 2024.
APA
Nucci, M., Anaissie, E. J., Queiróz-Telles, F., Martins, C. A., Trabasso, P., Solza, C., et al. (2003). Outcome predictors of 84 patients with hemetologic malignancies and fusarium infection. Cancer, 98( 2), 315-319. doi:10.1002/cncr.11510
NLM
Nucci M, Anaissie EJ, Queiróz-Telles F, Martins CA, Trabasso P, Solza C, Mangini C, Simões BP, Colombo AL, Vaz J, Levy CE, Costa S, Moreira VA, Oliveira JS, Paraguay N, Almeida GMD de, Volterelli JC, Maiolino A, Pasquini R, Souza CA. Outcome predictors of 84 patients with hemetologic malignancies and fusarium infection [Internet]. Cancer. 2003 ; 98( 2): 315-319.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.11510
Vancouver
Nucci M, Anaissie EJ, Queiróz-Telles F, Martins CA, Trabasso P, Solza C, Mangini C, Simões BP, Colombo AL, Vaz J, Levy CE, Costa S, Moreira VA, Oliveira JS, Paraguay N, Almeida GMD de, Volterelli JC, Maiolino A, Pasquini R, Souza CA. Outcome predictors of 84 patients with hemetologic malignancies and fusarium infection [Internet]. Cancer. 2003 ; 98( 2): 315-319.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cncr.11510
Artigo de periodico
Adrenocortical carcinoma: clinical and laboratory observations (2000)
Wajchenberg, Bernardo Leo; Pereira, Maria Adelaide Albergaria; Mendonça, Berenice Bilharinho de; Latronico, Ana Claudia; Carneiro, Paulo Campos; Alves, Venâncio Avancini Ferreira; Zerbini, Maria Cláudia Nogueira; Liberman, Bernardo; Gomes, Gilberto Carlos; Kirschner, Marvin A.
Source: Cancer. Unidade: FM
Assunto: PATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAJCHENBERG, Bernardo Leo et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer, v. 88, n. 4, p. 711-36, 2000Tradução . . Acesso em: 14 nov. 2024.
APA
Wajchenberg, B. L., Pereira, M. A. A., Mendonça, B. B. de, Latronico, A. C., Carneiro, P. C., Alves, V. A. F., et al. (2000). Adrenocortical carcinoma: clinical and laboratory observations. Cancer, 88( 4), 711-36.
NLM
Wajchenberg BL, Pereira MAA, Mendonça BB de, Latronico AC, Carneiro PC, Alves VAF, Zerbini MCN, Liberman B, Gomes GC, Kirschner MA. Adrenocortical carcinoma: clinical and laboratory observations. Cancer. 2000 ; 88( 4): 711-36.[citado 2024 nov. 14 ]
Vancouver
Wajchenberg BL, Pereira MAA, Mendonça BB de, Latronico AC, Carneiro PC, Alves VAF, Zerbini MCN, Liberman B, Gomes GC, Kirschner MA. Adrenocortical carcinoma: clinical and laboratory observations. Cancer. 2000 ; 88( 4): 711-36.[citado 2024 nov. 14 ]
Artigo de periodico
Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer (1995)
Milanez, J R C; Vargas, Francisco Suso; Filomeno, Luiz Tarcísio Brito; Teixeira, L.; Fernandez, A; Jatene, Fábio Biscegli; Light, R W
Source: Cancer. Unidades: EEFE, FM
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MILANEZ, J R C et al. Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer. Cancer, v. 75, n. ju 1995, p. 2688-91, 1995Tradução . . Disponível em: https://doi.org/10.1002/1097-0142(19950601)75:11%3C2688::aid-cncr2820751108%3E3.0.co;2-3. Acesso em: 14 nov. 2024.
APA
Milanez, J. R. C., Vargas, F. S., Filomeno, L. T. B., Teixeira, L., Fernandez, A., Jatene, F. B., & Light, R. W. (1995). Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer. Cancer, 75( ju 1995), 2688-91. doi:10.1002/1097-0142(19950601)75:11%3C2688::aid-cncr2820751108%3E3.0.co;2-3
NLM
Milanez JRC, Vargas FS, Filomeno LTB, Teixeira L, Fernandez A, Jatene FB, Light RW. Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer [Internet]. Cancer. 1995 ;75( ju 1995): 2688-91.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/1097-0142(19950601)75:11%3C2688::aid-cncr2820751108%3E3.0.co;2-3
Vancouver
Milanez JRC, Vargas FS, Filomeno LTB, Teixeira L, Fernandez A, Jatene FB, Light RW. Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer [Internet]. Cancer. 1995 ;75( ju 1995): 2688-91.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/1097-0142(19950601)75:11%3C2688::aid-cncr2820751108%3E3.0.co;2-3
Artigo de periodico
Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors (1992)
Brem, S; Tsanaclis, Ana Maria Crous; Gately, S; Gross, J L; Herblin, W F
Source: Cancer. Unidade: FM
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BREM, S et al. Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer, v. 70, n. 11, p. 2673-80, 1992Tradução . . Disponível em: https://doi.org/10.1002/1097-0142(19921201)70:11%3C2673::aid-cncr2820701118%3E3.0.co;2-f. Acesso em: 14 nov. 2024.
APA
Brem, S., Tsanaclis, A. M. C., Gately, S., Gross, J. L., & Herblin, W. F. (1992). Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer, 70( 11), 2673-80. doi:10.1002/1097-0142(19921201)70:11%3C2673::aid-cncr2820701118%3E3.0.co;2-f
NLM
Brem S, Tsanaclis AMC, Gately S, Gross JL, Herblin WF. Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors [Internet]. Cancer. 1992 ;70( 11): 2673-80.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/1097-0142(19921201)70:11%3C2673::aid-cncr2820701118%3E3.0.co;2-f
Vancouver
Brem S, Tsanaclis AMC, Gately S, Gross JL, Herblin WF. Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors [Internet]. Cancer. 1992 ;70( 11): 2673-80.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/1097-0142(19921201)70:11%3C2673::aid-cncr2820701118%3E3.0.co;2-f
Artigo de periodico
Statin immunolocalization in human brain tumors: detection of noncycling cells using a novel marker of cell quiescence (1991)
Tsanaclis, Ana Maria Crous; Brem, S S; Stevem, S; Gately, S; Schipper, H M; Wang, E
Source: Cancer. Unidade: FM
Assunto: PATOLOGIA CLÍNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TSANACLIS, Ana Maria Crous et al. Statin immunolocalization in human brain tumors: detection of noncycling cells using a novel marker of cell quiescence. Cancer, v. 68, n. 4 , p. 786-92, 1991Tradução . . Disponível em: https://doi.org/10.1002/1097-0142(19910815)68:4%3C786::aid-cncr2820680421%3E3.0.co;2-p. Acesso em: 14 nov. 2024.
APA
Tsanaclis, A. M. C., Brem, S. S., Stevem, S., Gately, S., Schipper, H. M., & Wang, E. (1991). Statin immunolocalization in human brain tumors: detection of noncycling cells using a novel marker of cell quiescence. Cancer, 68( 4 ), 786-92. doi:10.1002/1097-0142(19910815)68:4%3C786::aid-cncr2820680421%3E3.0.co;2-p
NLM
Tsanaclis AMC, Brem SS, Stevem S, Gately S, Schipper HM, Wang E. Statin immunolocalization in human brain tumors: detection of noncycling cells using a novel marker of cell quiescence [Internet]. Cancer. 1991 ;68( 4 ): 786-92.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/1097-0142(19910815)68:4%3C786::aid-cncr2820680421%3E3.0.co;2-p
Vancouver
Tsanaclis AMC, Brem SS, Stevem S, Gately S, Schipper HM, Wang E. Statin immunolocalization in human brain tumors: detection of noncycling cells using a novel marker of cell quiescence [Internet]. Cancer. 1991 ;68( 4 ): 786-92.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/1097-0142(19910815)68:4%3C786::aid-cncr2820680421%3E3.0.co;2-p
Artigo de periodico
Prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma (1989)
Bisi, Hélio; Fernandes, V. S. O.; Camargo, R. Y. A.; Koch, L.; Abdo, A. H.; Brito, T.
Source: Cancer. Unidade: FM
Subjects: CARCINOMA, GLÂNDULA TIREOIDE (FISIOPATOLOGIA), AUTÓPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BISI, Hélio et al. Prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma. Cancer, v. no 1989, n. 9, p. 1888-1893, 1989Tradução . . Disponível em: https://doi.org/10.1002/1097-0142(19891101)64:9%3C1888::aid-cncr2820640922%3E3.0.co;2-c. Acesso em: 14 nov. 2024.
APA
Bisi, H., Fernandes, V. S. O., Camargo, R. Y. A., Koch, L., Abdo, A. H., & Brito, T. (1989). Prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma. Cancer, no 1989( 9), 1888-1893. doi:10.1002/1097-0142(19891101)64:9%3C1888::aid-cncr2820640922%3E3.0.co;2-c
NLM
Bisi H, Fernandes VSO, Camargo RYA, Koch L, Abdo AH, Brito T. Prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma [Internet]. Cancer. 1989 ; no 1989( 9): 1888-1893.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/1097-0142(19891101)64:9%3C1888::aid-cncr2820640922%3E3.0.co;2-c
Vancouver
Bisi H, Fernandes VSO, Camargo RYA, Koch L, Abdo AH, Brito T. Prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma [Internet]. Cancer. 1989 ; no 1989( 9): 1888-1893.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/1097-0142(19891101)64:9%3C1888::aid-cncr2820640922%3E3.0.co;2-c
Artigo de periodico
Sensitivity, specificity and predictive value of laparoscopy for staging of gastric cancer and for the detection of liver metastases (1987)
Possik, R A; Franco, E L; Pires, D R; Wohnrath, D R; Ferreira, Eugênio Américo Bueno
Source: Cancer. Unidade: FM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POSSIK, R A et al. Sensitivity, specificity and predictive value of laparoscopy for staging of gastric cancer and for the detection of liver metastases. Cancer, v. 58, p. 1-6, 1987Tradução . . Disponível em: https://doi.org/10.1002/1097-0142(19860701)58:1%3C1::aid-cncr2820580102%3E3.0.co;2-k. Acesso em: 14 nov. 2024.
APA
Possik, R. A., Franco, E. L., Pires, D. R., Wohnrath, D. R., & Ferreira, E. A. B. (1987). Sensitivity, specificity and predictive value of laparoscopy for staging of gastric cancer and for the detection of liver metastases. Cancer, 58, 1-6. doi:10.1002/1097-0142(19860701)58:1%3C1::aid-cncr2820580102%3E3.0.co;2-k
NLM
Possik RA, Franco EL, Pires DR, Wohnrath DR, Ferreira EAB. Sensitivity, specificity and predictive value of laparoscopy for staging of gastric cancer and for the detection of liver metastases [Internet]. Cancer. 1987 ;58 1-6.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/1097-0142(19860701)58:1%3C1::aid-cncr2820580102%3E3.0.co;2-k
Vancouver
Possik RA, Franco EL, Pires DR, Wohnrath DR, Ferreira EAB. Sensitivity, specificity and predictive value of laparoscopy for staging of gastric cancer and for the detection of liver metastases [Internet]. Cancer. 1987 ;58 1-6.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/1097-0142(19860701)58:1%3C1::aid-cncr2820580102%3E3.0.co;2-k
Artigo de periodico
Carcinoembryonic antigen. A possible predictor of recurrence in cystosarcoma phyllodes (1986)
Alberti Junior, O; Brentani, Maria Mitzi; Goes, J C S; Lemos, L B; Torloni, H
Source: Cancer. Unidade: FM
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALBERTI JUNIOR, O et al. Carcinoembryonic antigen. A possible predictor of recurrence in cystosarcoma phyllodes. Cancer, v. 57, n. 5 , p. 1042-5, 1986Tradução . . Disponível em: https://doi.org/10.1002/1097-0142(19860301)57:5%3C1042::aid-cncr2820570528%3E3.0.co;2-f. Acesso em: 14 nov. 2024.
APA
Alberti Junior, O., Brentani, M. M., Goes, J. C. S., Lemos, L. B., & Torloni, H. (1986). Carcinoembryonic antigen. A possible predictor of recurrence in cystosarcoma phyllodes. Cancer, 57( 5 ), 1042-5. doi:10.1002/1097-0142(19860301)57:5%3C1042::aid-cncr2820570528%3E3.0.co;2-f
NLM
Alberti Junior O, Brentani MM, Goes JCS, Lemos LB, Torloni H. Carcinoembryonic antigen. A possible predictor of recurrence in cystosarcoma phyllodes [Internet]. Cancer. 1986 ;57( 5 ): 1042-5.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/1097-0142(19860301)57:5%3C1042::aid-cncr2820570528%3E3.0.co;2-f
Vancouver
Alberti Junior O, Brentani MM, Goes JCS, Lemos LB, Torloni H. Carcinoembryonic antigen. A possible predictor of recurrence in cystosarcoma phyllodes [Internet]. Cancer. 1986 ;57( 5 ): 1042-5.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/1097-0142(19860301)57:5%3C1042::aid-cncr2820570528%3E3.0.co;2-f

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Indexado em

Non normalized affiliation